From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2022

From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement

Résumé

Antibody-dependent cell-mediated cytotoxicity (ADCC) is a potent cytotoxic mechanism that is mainly mediated in humans by natural killer (NK) cells. ADCC mediates the clinical benefit of several widely used cytolytic monoclonal antibodies (mAbs), and increasing its efficacy would improve cancer immunotherapy. CD16a is a receptor for the Fc portion of IgGs and is responsible to trigger NK cell-mediated ADCC. The knowledge of the mechanism of action of CD16a gave rise to several strategies to improve ADCC, by working on either the mAbs or the NK cell. In this review, we give an overview of CD16a biology and describe the latest strategies employed to improve antibody-dependent NK cell cytotoxicity.
Fichier principal
Vignette du fichier
fimmu-13-913215.pdf (941.86 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03757448 , version 1 (22-08-2022)

Licence

Paternité

Identifiants

Citer

Loïs Coënon, Martin Villalba. From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. Frontiers in Immunology, 2022, 13, pp.913215. ⟨10.3389/fimmu.2022.913215⟩. ⟨hal-03757448⟩
22 Consultations
77 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More